SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MRVT Miravant Med Tech: Infinity and Beyond?
MRVT 0.00Jun 16 4:00 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Lacelle who wrote (55)11/29/2000 4:37:40 PM
From: Ian@SI   of 67
 
John,

You're wildly optimistic on the high side, IMO.

QLTI has had FDA approval for more than 6 months. It also been approved in many countries around the globe, including Canada, Europe and Asia.

More to the point, it has saturated Retinal Specialists offices with lasers for Visudyne which operate at a different wavelength than Snet2, or whatever MRVT is calling its drug now. Why would a Dr spend more money for redundant equipment that won't produce incremental revenue?

And QLT does have an extra couple years of Phase III data compared to MRVT. Retinal specialists would put much more faith in a drug which has been proven effective over 3 years rather than 1.

And some of the health care analysts suspect that MRVT has populated its Phase III study with very early stage AMD patients only. That may explain why it took MRVT longer than expected to populate its trial. If true, it may substantially impact the FDA approval process. I have no way of knowing whether or not it's true.

Clearly if MRVT meets its milestones, we'll see a bounce in the stock. But I'd be surprised if the old high is ever seen as a result of SnET2.

I'm not familiar enough with the rest of its pipeline to guesstimate the likely up or down side. I sold my shares when it became clear that MRVT would significantly trail QLTI.

FWIW,
Ian.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News